IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 170 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,098,000 | -45.2% | 395,574 | -2.4% | 0.29% | -28.6% |
Q3 2018 | $7,480,000 | -24.9% | 405,224 | -22.2% | 0.41% | -32.3% |
Q2 2018 | $9,959,000 | +41.5% | 520,888 | +14.2% | 0.60% | +18.1% |
Q1 2018 | $7,038,000 | +20.0% | 456,100 | +16.6% | 0.51% | +10.2% |
Q4 2017 | $5,864,000 | -14.7% | 391,200 | -10.3% | 0.46% | -19.7% |
Q3 2017 | $6,876,000 | +4.0% | 436,000 | +24.5% | 0.57% | -5.7% |
Q2 2017 | $6,610,000 | +10.7% | 350,096 | -0.0% | 0.61% | +1.7% |
Q1 2017 | $5,973,000 | -72.3% | 350,107 | -75.1% | 0.60% | -19.1% |
Q4 2016 | $21,528,000 | -3.7% | 1,408,000 | 0.0% | 0.74% | +1.1% |
Q3 2016 | $22,359,000 | +51.5% | 1,408,000 | +24.7% | 0.73% | +36.1% |
Q2 2016 | $14,762,000 | +299.7% | 1,129,000 | +389.2% | 0.54% | +407.5% |
Q1 2015 | $3,693,000 | – | 230,800 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |